Clinical Outcomes Utilizing Revascularization

Related by string. * clinicals . CLINICAL . Clinicals : Phase III clinical trials . placebo controlled clinical trials / OUTCOMES . OUTCOME : Improving Patient Outcomes . Main Outcome Measures / Utilized . utilized : utilizing CDMA IDEN . silicon wafers utilizing / revascularizations . revascularization : target lesion revascularization . Target Lesion Revascularization TLR * *

Related by context. Frequent words. (Click for all words.) 66 Acute Myocardial Infarction 64 Multicenter 63 Heart Failure Patients 62 Rosuvastatin 61 TAXUS Stent 61 Thrombolysis 61 Chronic Hepatitis C 61 Stenting 61 Clinical Trial Results 61 plus prednisone 60 multicenter clinical 60 PRECiSE 60 substudy 60 placebo controlled clinical 60 SYNTAX 59 Pivotal Phase 59 Tolerability 59 Pivotal Trial 59 Phase III Trial 59 Phase III Clinical Trial 59 Meta Analysis 59 TRITON TIMI 59 Arch Neurol 59 SPIRIT III 59 Drug Eluting Stents 59 randomized Phase III 59 SABCS 59 PRECISE 58 Myocardial Infarction 58 multicenter randomized 58 Randomized Controlled Trial 58 Arch Intern Med 58 plus dexamethasone 58 prospective randomized controlled 58 neoadjuvant 58 Coronary Stent 57 J Am Coll 57 Pivotal Phase III 57 prospective observational 57 J Natl Cancer Inst 57 HALTS 57 randomized controlled clinical 57 Clopidogrel 57 Systematic Review 57 Chronic Lymphocytic Leukemia 56 Acute Coronary Syndrome 56 ACC AHA 56 Catheterization 56 CYPHER ® Stent 56 Rivaroxaban 56 composite endpoint 56 liver transplant recipients 56 stable angina 56 phase IIa 56 coronary revascularization 56 randomized controlled clinical trials 56 ALLHAT 56 Phase Ib clinical 56 Amrubicin 56 Monotherapy 56 metastatic hormone refractory 56 J Clin Oncol 56 Ann Intern Med 56 cerebrovascular events 56 Pharmacokinetic 56 Free Full Text 56 Cardiovascular Risk 56 placebo controlled trials 56 Gynecologic Oncology Group 56 pertuzumab 56 J Am Acad 56 nesiritide 55 virologic response 55 carotid artery stenting 55 Cardiol 55 Stent System 55 irbesartan 55 Completes Enrollment 55 multicenter study 55 randomized clinical 55 immunohistochemical 55 #:#-# [031] 55 tolvaptan 55 Phase 2b study 55 Phase 1b trial 55 label multicenter 55 neoadjuvant therapy 55 metastatic renal cell carcinoma 55 active comparator 55 Taxotere ® 55 Phase III randomized 55 Xience V 55 PROMACTA 55 Clinical Endocrinology & 55 plus gemcitabine 55 PREVAIL 54 mg QD 54 COURAGE 54 Pirfenidone 54 tipranavir 54 endarterectomy

Back to home page